Most Read News
- Pfizer to Acquire Hospira
- Study shows Tamiflu gets patients back on their feet faster, reduces flu complications
- Four initiatives from across Africa win share of global US$1 million Healthcare Innovation Award
- High-cost blood cancer drugs deliver high value
- AstraZeneca to acquire rights to Actavis’ branded respiratory portfolio in the US and Canada
- Add nature, art and religion to life's best anti-inflammatories
- A new screening method may be able to identify toxic drugs earlier in development
Company Profiles and News
Abbott |
Amgen |
AstraZeneca |
Bayer |
Boehringer Ingelheim |
Bristol-Myers Squibb |
Daiichi Sankyo |
Eli Lilly and Company |
Genzyme |
GlaxoSmithKline |
Lundbeck |
Merck |
Merck KGaA |
Novartis |
Novo Nordisk |
Nycomed |
Pfizer |
Roche |
Sanofi |
Shire |
Takeda |
UCB | ...
Showcase your Company Profile / News
Showcase your Company Profile / News
Pharmaceutical Companies
Business & Industry News
- Shire acquires Meritage Pharma
- Novartis receives FDA approval of Farydak®, the first HDAC inhibitor for patients with multiple myeloma
- Sanofi and Lead Pharma to develop treatments for autoimmune diseases
- GSK strengthens early stage vaccine pipeline with acquisition of GlycoVaxyn AG
- Roche acquires Signature Diagnostics to advance translational research for next generation sequencing (NGS) diagnostics
- Bayer forms collaboration with academic and governmental institutions for Rivaroxaban study
- Pfizer to Acquire Hospira
Research & Development News
- Drug research and development more efficient than expected
- Omega-3 fatty acids and vitamin D may control brain serotonin
- Graphene shows potential as novel anti-cancer therapeutic strategy
- Safety and life-saving efficacy of statins have been exaggerated
- Palbociclib shows promise in patients with hormone-resistant breast cancer
- iManageCancer Survey: Your Opinion Counts
- New nanogel for drug delivery
Regulatory Affairs News
- FDA approves anti-clotting drug Savaysa
- FDA warns consumers about fraudulent Ebola treatment products
- FDA issues guidance to support the responsible development of nanotechnology products
- FDA launches openFDA to provide easy access to valuable FDA public data
- FDA requires removal of certain restrictions on the diabetes drug Avandia
- EMA and US FDA release first conclusions of parallel assessment of quality-by-design applications
- FDA approves new drug to treat HIV infection